
Christopher R. Stone
Examiner (ID: 15088, Phone: (571)270-3494 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1609, 1628, 4173, 1614 |
| Total Applications | 750 |
| Issued Applications | 250 |
| Pending Applications | 42 |
| Abandoned Applications | 457 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18314117
[patent_doc_number] => 11628177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Compositions and methods for deep dermal drug delivery
[patent_app_type] => utility
[patent_app_number] => 17/527856
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10091
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527856
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527856 | Compositions and methods for deep dermal drug delivery | Nov 15, 2021 | Issued |
Array
(
[id] => 19083031
[patent_doc_number] => 20240109832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => RAPID CONSTRUCTION OF TETRALIN, CHROMANE, AND INDANE MOTIFS VIA CYCLATIVE C-H/C-H COUPLING: FOUR-STEP TOTAL SYNTHESIS OF (+-)-RUSSUJAPONOL F
[patent_app_type] => utility
[patent_app_number] => 18/252655
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252655
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252655 | RAPID CONSTRUCTION OF TETRALIN, CHROMANE, AND INDANE MOTIFS VIA CYCLATIVE C-H/C-H COUPLING: FOUR-STEP TOTAL SYNTHESIS OF (+-)-RUSSUJAPONOL F | Nov 8, 2021 | Pending |
Array
(
[id] => 17913172
[patent_doc_number] => 20220315567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Substituted Ureas and Methods of Making and Using Same
[patent_app_type] => utility
[patent_app_number] => 17/520350
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520350
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/520350 | Substituted Ureas and Methods of Making and Using Same | Nov 4, 2021 | Abandoned |
Array
(
[id] => 18733412
[patent_doc_number] => 11802135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Lysophosphatidic acid derivative
[patent_app_type] => utility
[patent_app_number] => 17/518212
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 59315
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/518212 | Lysophosphatidic acid derivative | Nov 2, 2021 | Issued |
Array
(
[id] => 18747052
[patent_doc_number] => 11806341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Methods of diagnosing and treating anxiety disorder
[patent_app_type] => utility
[patent_app_number] => 17/512827
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 46
[patent_no_of_words] => 55801
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512827 | Methods of diagnosing and treating anxiety disorder | Oct 27, 2021 | Issued |
Array
(
[id] => 17576847
[patent_doc_number] => 20220133702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/513060
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513060 | CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE | Oct 27, 2021 | Abandoned |
Array
(
[id] => 18747051
[patent_doc_number] => 11806340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Methods of diagnosing and treating conduct disorder
[patent_app_type] => utility
[patent_app_number] => 17/511795
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 46
[patent_no_of_words] => 59779
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511795 | Methods of diagnosing and treating conduct disorder | Oct 26, 2021 | Issued |
Array
(
[id] => 19091063
[patent_doc_number] => 11952495
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-04-09
[patent_title] => Fluorogenic pH-sensitive compounds and their methods of use
[patent_app_type] => utility
[patent_app_number] => 17/498377
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 57
[patent_no_of_words] => 29158
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/498377 | Fluorogenic pH-sensitive compounds and their methods of use | Oct 10, 2021 | Issued |
Array
(
[id] => 20206358
[patent_doc_number] => 20250276078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => Camptothecin Derivative And Ligand-drug Conjugate Thereof
[patent_app_type] => utility
[patent_app_number] => 18/030754
[patent_app_country] => US
[patent_app_date] => 2021-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030754
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030754 | Camptothecin Derivative And Ligand-drug Conjugate Thereof | Oct 8, 2021 | Pending |
Array
(
[id] => 18995864
[patent_doc_number] => 11912691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Tocotrienols derivates, methods and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/030775
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 8679
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030775
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030775 | Tocotrienols derivates, methods and uses thereof | Oct 7, 2021 | Issued |
Array
(
[id] => 18769240
[patent_doc_number] => 20230363996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => HAIR CARE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/029734
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029734
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029734 | HAIR CARE COMPOSITION | Oct 4, 2021 | Pending |
Array
(
[id] => 18806827
[patent_doc_number] => 20230381160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => PROPHYLATIC USE OF CALCIUM CHANNEL BLOCKERS IN TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 18/028233
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028233
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028233 | PROPHYLATIC USE OF CALCIUM CHANNEL BLOCKERS IN TUBERCULOSIS | Sep 23, 2021 | Pending |
Array
(
[id] => 18056221
[patent_doc_number] => 20220387307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHOD OF TREATING DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/479780
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479780 | METHOD OF TREATING DISEASE | Sep 19, 2021 | Abandoned |
Array
(
[id] => 17333781
[patent_doc_number] => 20220000112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT
[patent_app_type] => utility
[patent_app_number] => 17/476407
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/476407 | DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | Sep 14, 2021 | Abandoned |
Array
(
[id] => 19914730
[patent_doc_number] => 12290073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => Anti-microbial compound and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/447446
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 13670
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/447446 | Anti-microbial compound and methods of use | Sep 12, 2021 | Issued |
Array
(
[id] => 17441692
[patent_doc_number] => 20220062197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => 7-OH-CANNABIDIOL (7-OH-CBD) AND/OR 7-OH-CANNABIDIVARIN (7-OH-CBDV) FOR USE IN THE TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 17/472000
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472000
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472000 | 7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy | Sep 9, 2021 | Issued |
Array
(
[id] => 17460176
[patent_doc_number] => 20220073481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => BIMETAL OXIDE CATALYST AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/472243
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472243 | Bimetal oxide catalyst and methods | Sep 9, 2021 | Issued |
Array
(
[id] => 18384464
[patent_doc_number] => 11655232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
[patent_app_type] => utility
[patent_app_number] => 17/465668
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 54
[patent_no_of_words] => 10496
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465668 | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione | Sep 1, 2021 | Issued |
Array
(
[id] => 18656113
[patent_doc_number] => 20230301988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/023661
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023661
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023661 | INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF | Aug 25, 2021 | Pending |
Array
(
[id] => 18692413
[patent_doc_number] => 20230322647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => PCNHCP METAL COMPLEXES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/042752
[patent_app_country] => US
[patent_app_date] => 2021-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042752
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042752 | PC | Aug 21, 2021 | Issued |